jump to navigation

Finally back with news June 27, 2008

Posted by hiiroki in Misc.
1 comment so far

Well after 2 weeks of nothing on the blog, because I was hell busy and very depressed with having not much hair on my head.

So I finally put up news again :S

And this is my new haircut and new specs(my old lenses warped) :S, man, one of them, I look like lecturer.

Before (without glasses) and After:-

Well, will say more next time.

Cheers

PODCAST ALERT: Novel Method for Remyelinating Nerve Cells June 27, 2008

Posted by hiiroki in Biotech News.
add a comment

(more…)

Neuroscience Newsletter from Biocompare (27 June 2008) June 27, 2008

Posted by hiiroki in Biotech News.
add a comment

Courtesy of Biocompare.

(more…)

Genomics Newsletter from Biocompare (27 June 2008) June 27, 2008

Posted by hiiroki in Biotech News.
add a comment

Courtesy of Biocompare.

(more…)

Life Science Newsletter from Biocompare (27 June 2008) June 27, 2008

Posted by hiiroki in Biotech News.
add a comment

Courtesy of Biocompare.

(more…)

Cancer Newsletter from Biocompare (27 June 2008) June 27, 2008

Posted by hiiroki in Biotech News.
add a comment

Courtesy of Biocompare.

(more…)

Implications of GINA for the Biotech and Pharma Industries June 27, 2008

Posted by hiiroki in Biotech News.
add a comment
The GENcast NETWORK ALERT


Create Your Own Portfolio


PODCAST: “Implications of GINA for the Biotech and Pharma Industries”

—Sharon Terry, President and CEO of the Genetic Alliance, is interviewed by GEN’s Editor in Chief, John Sterling.

WHEN: June 19— June 26, 2008

President Bush’s recent signing into law of the Genetic Information Nondiscrimination Act (GINA) is not only a victory for individuals but for biotech and pharmaceutical companies as well. GINA is the first and only federal legislation that will provide protection against discrimination based on an individual’s genetic information in health insurance coverage and employment settings.

During this week’s GEN podcast, Sharon Terry, from the Genetic Alliance, discusses how GINA will allow the promise of genetic testing and disease management and prevention to be more fully realized. She explores both the implications of GINA’s passage for companies carrying out biotech or pharmaceutical research and the opportunities that GINA opens up for these companies. Terry also explains how the overall U.S. healthcare system and companies specifically involved in the development of personalized medicine will be impacted by GINA.

LISTEN NOW to this week’s GEN Podcast.

Email to a colleague

Molecular Biology Newsletter from Biocompare (27 June 2008) June 27, 2008

Posted by hiiroki in Biotech News.
add a comment

Courtesy of Biocompare.

(more…)